BlackRock launches iShares US biotech ETF
TER of 0.35%
BlackRock launches US biotech ETF
BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.
Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...
More on ETFs
Industry experts divided over whether ETFs should make daily portfolio disclosures
Changes made on 14 September
Morningstar IM Europe rings the changes across passive range
Cash levels reduced
Vanguard changes screening process on two SRI index funds
Effective 24 September
Where there's still opportunity in US stock markets
More news
IW Poll: What will be the outcome of the Brexit negotiations?
Four potential outcomes
Video: Keeping up with CASCAID - the abseil challenge
Industry members abseil down Broadgate Tower
Industry experts divided over whether ETFs should make daily portfolio disclosures
Changes made on 14 September
Newton IM hires Polar Capital's Mackirdy to replace Clark
Hired as portfolio manager in global equity income team
Carmignac's Saint-Georges: US policies 'hoovering' up liquidity and global growth
'Three cycles are colliding'
Back to Top